Tag: ESOC 2026
Stroke thrombectomy beyond 24 hours improves functional outcome but carries increased...
Mechanical thrombectomy can lead to an improvement in 90-day functional outcome compared to standard medical care in anterior-circulation large vessel occlusion (LVO) stroke patients...
Tirofiban demonstrates adjunctive advantages alongside thrombolysis and thrombectomy across multiple trials
This year’s European Stroke Organisation Conference (ESOC; 6–8 May, Maastricht, Netherlands) saw late-breaking presentations from multiple clinical trials indicating the benefits of tirofiban—a potent...
Arterial widening identified as potential underlying cause of small vessel disease...
A recent study has found that the buildup of fatty deposits in arteries does not appear to cause lacunar ischaemic stroke, with a different...
Asundexian found to reduce severity of secondary strokes
Bayer has announced late-breaking data from new analyses of the phase-three OCEANIC-STROKE study comparing asundexian versus placebo in combination with antiplatelet therapy. These analyses—presented...
Flat-detector CT shows high ICH detection accuracy but ultimately falls short...
New findings from the SPINNERS trial demonstrate that—despite the trial failing to achieve non-inferiority as per its primary endpoint—the syngo DynaCT Sine Spin (Siemens...
Debate heats up following contrasting trial results on brain cooling during...
Two randomised trials presented this week at the European Stroke Organisation Conference (ESOC; 6–8 May 2026, Maastricht, Netherlands) have generated new evidence on the...
Stenting during thrombectomy fails to fully establish non-inferiority versus deferred treatment...
While carotid artery stenting (CAS) during mechanical thrombectomy appears to be safe, whether or not the approach is non-inferior to deferred management remains to...
Full DISTALS results confirm efficacy and safety of Tigertriever 13 thrombectomy...
Rapid Medical has announced full results from the DISTALS randomised controlled trial, which were presented today at the 2026 European Stroke Organisation Conference (ESOC;...
Very low and very high heart rates both found to be...
A new study presented earlier today at the 2026 European Stroke Organisation Conference (ESOC; 6–8 May, Maastricht, Netherlands) suggests that both very low and...
Intra-arterial tenecteplase safe but does not improve reperfusion after incomplete thrombectomy
Today, at the 2026 European Stroke Organisation Conference (ESOC; 6–8 May, Maastricht, Netherlands), findings from the TECNO trial were presented for the first time,...
Reperfusion-guided strategy to post-thrombectomy BP management shows improvement in functional outcomes
A systolic blood pressure (BP) management strategy tailored to the degree of reperfusion after successful mechanical thrombectomy can improve 90-day functional outcomes in patients...
UK register reveals rising stroke rates as well as widening ethnic...
A new study presented today at the 2026 European Stroke Organisation Conference (ESOC; 6–8 May, Maastricht, Netherlands) shows that, after decades of decline, stroke...
